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Introduction
Dystonia is a movement disorder characterized by sustained 
or intermittent muscle contractions causing abnormal, 
often repetitive movements, abnormal posturing, or both. 
Dystonia comprises a heterogeneous patient population 
due to a broad spectrum of underlying acquired and inher-
ited etiologies [1].
Over the past decades, deep brain stimulation of the 
globus pallidus internus (GPi-DBS) has emerged as a safe 
treatment option with a good response in non-lesional, 
mostly isolated forms of dystonia and a more variable 
response in combined forms of dystonia that are due to a 
static lesion or neurodegenerative process [2]. The applic-
ation of this elective neurosurgical procedure therefore 
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frequently gives rise to discussion, especially in secondary 
dystonia patients.
The effect of GPi-DBS has been predominantly meas-
ured with objective standardized dystonia rating scales [2]. 
However, the variability of dystonic symptoms within days, or 
even hours or minutes, makes it difficult to reliably capture 
overall dystonia severity in just one evaluation. Furthermore, 
it is unclear how dystonia severity reflects disease burden 
and there is only weak evidence that a reduction in symp-
toms in isolated forms of dystonia may correlate with mean-
ingful improvements in functioning [3, 4].
In line with the World Health Organization guidelines 
advocating patient-centered outcome measures [5], we 
aimed to systematically evaluate the effect of DBS in terms 




We prospectively included fifteen consecutive dystonia 
patients that received GPi-DBS between January 2013 
and July 2016. All patients were evaluated pre and 1-year 
post-operatively screened by a multidisciplinary team. The 
local ethical committee classified the study as care as usual.
Outcome measures
Priorities were identified by the Canadian Occupational 
Performance Measure (COPM). The COPM is an individual-
ized outcome measure to capture everyday problems that 
impact daily functioning. Together with a trained occu-
pational therapist, patients and/or caregivers imaginary 
walked through a typical day in the patient’s life to identify 
priorities that they would like to see improved by GPi-DBS. 
For the three most important priorities performance (1–10) 
and satisfaction (1–10) were rated. Change between pre- 
and postoperative ratings was used for further analyses. At 
the 1-year follow-up, patients and/or their caregivers were 
blinded for their pre-operative ratings. A difference of two 
or more points was considered clinically significant [6].
Dystonia severity was assessed with the motor subscale 
of the Burke-Fahn-Marsden dystonia rating scale (BFMDRS). 
Videos were blinded for operative status and rated by exper-
ienced clinicians (ALB, RB, KJP, MFC) who were blinded to 
treatment state. Mean total scores were calculated. In order 
to be able to compare the results in all patients (generalized 
and focal/segmental) the relative change in BFMDRS (% of 
improvement) was used for further analyses. In addition, 
patients were subdivided into motor ‘responders’ (>20% 
change in BFMDRS score) and ‘non-responders’ (<20% 
change in BFMDRS score) [7]. For absolute scores, see sup-
plementary Table 1.
Data-analysis
Data-analysis was performed using Statistical Package for 
the Social Sciences (SPSS, version 23.0). Due to the hetero-
geneity of the sample, medians and interquartile ranges 
(IQR) were used. Differences between pre- and postoperat-
ive scores were compared with the Wilcoxon Signed Ranked 
Test for total group and the responders and non-responder 
subgroups. Correlations between the outcome measures 
were calculated with the Spearman’s ρ.
Results
Baseline characteristics, etiology and pharmacological treat-
ment of all 15 patients (8 male; median age 32y range 8–65; 
median disease duration 8y range 3–47) are shown in Table 1.
Individual priorities
The 45 priorities (3 per patient) were categorized in self-care/
activities of daily living (ADL) (n = 10); comfort in sitting and 
sleep (n = 9); communication (n = 7); social/leisure activit-
ies (n = 7); and mobility (n = 12). Communication priorities 
involved the ability to use an electric communication device, 
sign language or normal social interaction without interfer-
ence of dystonic posturing. Social activities included sports, 
interactive games or going out for dinner. Mobility comprised 
walking, cycling, driving a car or the use of public transport.
For each patient, priorities comprised at least two categor-
ies. There was a very strong correlation between perform-
ance and satisfaction scores (ρ = 0.86, p < 0.0001) and both 
scores significantly improved after the application of DBS 
(Table 2). At patient level, a clinically significant change in 
satisfaction in two or three individual priorities was repor-
ted in 73% (11) of the patients. In 47% all three priorities 
were improved, in 27% two priorities were improved, in 
13% one priority was improved and in 13% none of the pri-
orities was improved.
Dystonia severity
BFMDRS scores improved with a median change of 30% (pre 
46.8 IQR 17.0–66.0 vs post 35.4 IQR 11.3–53.0; p = 0.027). 
For absolute changes, see supplementary table 1. Eight 
patients (53%) were classified as responders with a decrease 
in their BFMDRS of more than 20% and seven (47%) as 
non-responders.
The non-responders were two patients with cerebral palsy 
(case 8 and 14), one patient with a mitochondrial disorder 
(case 1), one patient with DYT-THAP1 (case 6) and three 
patients with segmental dystonia (case 3, 12 and 15).
Priorities versus dystonia severity
Change in dystonia severity did neither correlate with 
change in performance (ρ = –0.15, p = 0.601) nor satisfac-
tion score (ρ = 0.17, p = 0.557).
Seven of the eight responders reported a clinically signi-
ficant improvement in performance and satisfaction on at 
least two or three individual functional priorities. In the 
group of non-responders, despite the lower motor response, 
clinical significant improvement in at least two priorities 
was achieved in four of these patients for performance and 
three for satisfaction, with a statistically significant change 
in COPM score (Case 6, 12, 14 and 15, p = 0.017).
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Discussion
This prospective case series aimed to systematically evalu-
ate the effectiveness of GPi-DBS as measured with change 
in preoperatively set functional priorities. The priorities of 
the patients and their caregivers lay within the domains of 
ADL, seating and sleep, communication, social/leisure activ-
ities and mobility. A clinically significant motor response 
coincided with improvements in functional priorities in 7/8 
patients. Interestingly, half of the motor ‘non-responder’ 
patients also showed a clinically significant change in two 
or three priorities. Our findings are in line with a previous 
study in childhood dystonia showing that DBS may lead to 
improvement of functional goals also in patients with only 
moderate to ‘insignificant’ motor response [8].















Gabapentin 100 mg; intra thecal 
baclofen 3 ug/hr
Unchanged
2 M/8 Generalized Isolated Idiopathic THP 20 mg No
3 M/18 Segmental Isolated Idiopathic THP 24 mg; BTX THP 24 mg
4 F/22 Generalized Isolated ACTB mutation THP 16 mg; tramadol 50 mg THP 12 mg; clonazepam 
1.5 mg; clozapine 18.75; BTX
5 F/32 Segmental Isolated Idiopathic Ibuprofen; BTX No
6 M/9 Generalized Isolated DYT-THAP1 THP 21 mg; baclofen 12.5 mg THP 11 mg
7 M/22 Segmental Isolated TTPA Vitamin E Unchanged
8 M/47 Generalized Combined 
(spasticity)
Cerebral palsy Antidepressants Unchanged
9 M/53 Segmental Isolated Idiopathic Clonazepam 0.5 mg; BTX BTX
10 F/65 Segmental Combined 
(parkinsonism)
Idiopathic Pramipexole; L-dopa; Diazepam 
5 mg; BTX
Pramipexole; L-Dopa
11 F/48 Generalized Isolated ACTB mutation THP 12 mg; clozapine 12.5 mg; 
oxazepam 10 mg; diclofenac; 
BTX antidepressant
THP 12 mg; clozapine 
12.5 mg; antidepressant
12 F/63 Segmental Isolated Idiopathic Clonazepam 2.5 mg Clonazepam 0.5 mg
13 M/62 Segmental Isolated Idiopathic BTX Clonazepam 1.0 mg; BTX
14 F/8 Generalized Combined 
(spasticity)
Cerebral palsy THP 1.5 mg; baclofen 12 mg; gaba-
pentin 600 mg; clonazepam 0.5 mg
Unchanged
15 F/63 Segmental Isolated Idiopathic No No
ACTB: beta-actin gene; BTX: botulinum toxin injections; THP: trihexiphenidyl; TTPA α-tocopherol transfer protein – vitamin E.
Table 2: Pre- and postoperative COPM scores for all functional priorities and per subcategory.
COPM-Performance COPM-Satisfaction
Baseline 1 year Improved 
priorities†
Baseline 1 year Improved 
priorities†
All priorities 3.0 (1.0–4.0) 7.0 (5.0–8.0) 32/45* 2.0 (1.0–3.5) 7.0 (4.0–8.5) 31/45*
Sitting and sleep 3.0 (2.0–4.0) 7.0 (5.5–8.0) 8/9 2.0 (1.5–3.5) 7.0 (3.5–9.0) 5/9
Self-care/ADL 1.5 (1.0–4.3) 6.0 (2.5–7.3) 6/10 1.5 (1.0–3.0) 6.5 (2.5–7.3) 7/10
Communication 4.0 (3.0–4.0) 8.0 (6.0–10.0) 5/7 3.0 (1.0–4.0) 9.0 (7.0–9.0) 6/7
Social/leisure 3.0 (1.0–4.0) 7.0 (3.0–7.0) 4/7 3.0 (1.0–4.0) 6.0 (1.0–7.0) 4/7
Transfer 2.5 (1.3–4.8) 6.5 (5.3–7.0) 9/12 2.0 (1.0–3.8) 6.5 (5.3–8.8) 9/12
ADL activities of daily living; † Change or 2 point or more between baseline and 1-year post-operative score. * p < 0.0001.
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In contrast to the vast majority of efficacy studies primarily 
focusing on motor response, we evaluated effect of GPi-DBS 
by looking at functional priorities. These priorities provide 
an unique insight in what patients and their caregivers 
identify as most important aspects in daily living. Given the 
heterogeneous nature of dystonia, it is not surprising that 
needs varied greatly between patients. An additional advant-
age is that this method may facilitate recognition of patients 
that might be unsuitable for the procedure due to goals that 
are unrealistic or not likely to be achieved by GPi-DBS. One 
might argue that with a goal-oriented approach changes 
are subjective to the patients’ perception of improvement 
rather than objective symptom reduction. In addition, a 
potential placebo effect cannot be excluded in the absence 
of a control group. However, we agree with Kubu and col-
leagues that the main goal of DBS is to improve quality of 
life as perceived by the patient more than by the clinician, 
and that the effect of an elective neurosurgical option as 
DBS should be measured accordingly [9]. In the future, it 
would be useful to objectify the patient centered outcome. 
This can be done by transforming the patients’ priorities 
into a treatment goal and pre-operatively decide with the 
patient and caregivers when the goal is met, for instance by 
using the goal attainment scale.
The heterogeneous patient sample may be seen as a limit-
ation, both in terms of age as well as etiology. On the other 
hand, it can be seen as an advantage for the generalizability 
of the study. We did not correct for changes in medication, 
which could account for some of the perceived improve-
ments. We realize that our conclusions are bases on a small 
case series with a possibly limited power, but hope these 
results serve as a pilot study to trigger future studies focus-
ing on the effectiveness of GPi-DBS in dystonia. First to 
assess to what extent a good motor outcome corresponds 
with the perceived outcome on the patient’s priorities. 
This may not always be the case, as 1/8 motor responders 
did not reach a significant improvement on his priorities, 
and might provide clarity in the repeatedly reported dis-
crepancy between motor outcome and patient reported 
outcome. A systematical use of patient centered outcomes 
might shine a new light on the current opinion that GPi-
DBS is more effective in isolated than in combined forms 
of dystonia.
In conclusion, the effect of GPi-DBS should be measured 
not by motor symptom reduction alone, as clinically signi-
ficant improvements on individual predefined priorities can 
be achieved irrespective of motor response. In addition, a 
goal- or patient-oriented approach provides unique insights 
in the priorities in daily living of dystonia patients and their 
caregivers. This may not only be of added value for DBS 
candidates, but also for patients across the entire dystonia 
population.
Appendix
Supplementary Table 1: Absolute Burke-Fahn-Marsden Dystonia Rating Scale score pre- and postoperatively (n = 15).
Pt Gender/age 
(yr)




1 M/8 Generalized Combined 66 70
2 M/8 Generalized Isolated 55 31
3 M/18 Segmental Isolated 47 44
4 F/22 Generalized Isolated 81 33
5 F/32 Segmental Isolated 33 13
6 M/9 Generalized Isolated 71 69
7 M/22 Segmental Isolated 14 5
8 M/47 Generalized Combined 49 53
9 M/53 Segmental Isolated 23 14
10 F/65 Segmental Combined 16 8
11 F/48 Generalized Isolated 64 45
12 F/63 Segmental Isolated 17 18
13 M/62 Segmental Isolated 20 11
14 F/8 Generalized Combined 102 107
15 F/63 Segmental Isolated 9 10
* Mean BFMDRS-M was calculated from the two scores of the experts.
BFMDRS-M: Burke-Fahn-Marsden Dystonia Rating Scale, Motor subcale; DBS: Deep brain stimulation.
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